The latest medical insurance reimbursement range for trametinib, is it cheap?

Trametinib (Trametinib) is used alone or in combination with dabrafenib to treat certain types of skin cancer (melanoma), lung or thyroid cancer. It is also used to treat solid tumors in adults and children at least 6 years old. It is also used to treat a type of brain tumor called low-grade glioma in adults and children at least 1 year old. Patients are often given trametinib when the cancer has spread to other parts of the body, when surgery is not an option, or to prevent the cancer from coming back after surgery.

The original drug of trametinib has been marketed in China and is included in the scope of medical insurance, but it may be limited to patients who meet the indications. Its reimbursement conditions are similar to those of dabrafenib, including the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma and adjuvant therapy after complete resection of stage III melanoma patients; patients with BRAF V600 mutation-positive metastatic non-small cell lung cancer. Common domestic specificationsThe price of 2mg*30 tablets is more than RMB 10,000. The reimbursed price may vary according to the different reimbursement ratios in different regions, but it will be slightly lower than the original price. Patients can consult with the local medical insurance bureau or hospital.

The Turkish version of the original drug Trametinib currently sold overseasThe price of 2mg*30 tablets is more than RMB 7,000 (the price may fluctuate due to exchange rates). There are also generic trametinib drugs produced in other countries overseas, and their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of a 2mg*30 tablet of a generic drug produced by a Laos pharmaceutical factory is more than 2,000 yuan (the price may fluctuate due to the exchange rate). For specific prices and drug information of overseas drugs, please consult Yaode Medical Consultant.